Geron Corporation (GERN) Presents Interim Clinical Data on Its Telomerase Inhibitor Drug at AACR-NCI-EORTC
11/19/2009 8:39:52 AM
More...
|
Geron Corporation (GERN) Collaborators Publish Data on hESC-Derived Glial Progenitor Cell Therapy in Cervical Spinal Cord Injury
11/11/2009 9:41:29 AM
More...
|
Geron Corporation (GERN) (JOBS), FDA Agree on Spinal Injury Drug Trial
11/2/2009 7:25:02 AM
More...
|
Geron Corporation (GERN) and FDA Reach Agreement on Clinical Hold
10/30/2009 11:12:46 AM
More...
|
Geron Corporation (GERN) Reports 2009 Third Quarter Financial Results and Events
10/30/2009 9:19:15 AM
More...
|
Geron Corporation (GERN) Announces Conference Call to Discuss Financial Results for the 2009 Third Quarter
10/27/2009 10:00:31 AM
More...
|
Geron Corporation (GERN) Announces Direct Equity Issuance
9/10/2009 10:11:24 AM
More...
|
Calvin B. Harley to Retire as Chief Scientific Officer of Geron Corporation (GERN)
9/8/2009 1:38:08 PM
More...
|
Geron Corporation (GERN) to Present at Four Investor Conferences
8/31/2009 9:33:11 AM
More...
|
Geron Corporation (GERN) (JOBS) Comments on FDA Hold on Spinal Cord Injury Trial
8/27/2009 6:42:47 AM
More...
|
|